Parace Bionics, LLC is a New York based medical technology (MedTech) company that is on a mission to create innovative MedTech solutions to address a group of diseases that claim the lives of millions of people worldwide and afflict numerous. We strive to invent and deliver affordable, life-saving medical technologies, to meet the needs of people requiring healthcare, all over the world.


The 1958 Nobel Prize laureate, Joshua Lederberg stated that “the single biggest threat to man’s continued dominance on this planet is the virus.” This fact is undeniable with the emergence of the Covid-19 virus, which continues to disrupt the way of life for billions of people…

We envision a world free of diseases, particularly in developing countries. We envision a world whereby every child and person will be able to see a doctor, nurse or PA, to receive preventative medical care and treatments, thereby preserving lives. We envision a world whereby our state -of- the -art technologies, like the EKOSCOPE ® will be utilized on the frontline, to assess and diagnose early signs of heart and lung diseases in the most expedient manner. Our vision is to help make the world a better place, one country at a time.


The adage, “Necessity is the mother of invention”, ascribed to the Greek philosopher Plato, is a mantra that motivates us. We are driven to invent because cardiovascular disease, diabetes, kidney disease and the complications associated with aging continue to be leading causes of morbidity and mortality around the world. Unlike technological breakthroughs that have allowed mankind to enter the realms of outer space, medical technologies and innovations have lagged behind in our biological inner space. We are therefore motivated to make technical advances where others have overlooked or deprioritized. Though our present focus is on cardiovascular and circulatory system, we are motivated to address other diseases such as oncological and hematological conditions.


Parace Bionics’ name is derived from “Par” – equality, and “Ace” - to excel. Parace therefore means to strive for excellence & care for others. It’s a simple motto that guides the company’s culture and endeavors.

The company’s history dates back to 2004, with the filing of its first patent, by a body of clinical/medical professionals, who possessed the foresight to set out on a quest to invent and patent innovative technologies, curtailed to meet the needs of people, who are suffering from cardiovascular diseases and other chronic life threatening and debilitating chronic conditions, particularly in the developing world.

After more than a decade of research & collaboration with STEM universities in the United States, the company has made great strides in developing game changing technologies, such as an optical device that uses the visible spectrum of light to non-invasively quantify mmol of blood sugar level in vivo; and the development of a PPE apparatus that uses optical means to purify ambient air, reaching 100% virus free levels.

The company is known globally for the development of its flagship product, the EKOSCOPE ®, which is an FDA approved device, designed to aid in the diagnosis of cardiac arrhythmias and their associated disease states, by digitally processing heart sounds and ECG data in seconds.

The company has recently received United State patent for a cost-effective solution for bed bound patients, who are prone to decubitus ulcer and life-threatening infections therefrom. The company has been granted four U.S. patents in 2021 and has received more than a dozen patents to date. The company also has several registered & pending trademarks in USA, Europe and China.

President & CEO

The company’s President & CEO is Carolyn Whatley, MD, MPH, SHM; a Harvard Medical School and Public Health graduate; a clinical assistant professor; an internist with more than 15 years of experience as a transformational physician leader/medical director. Dr. Whatley is an active member of the American Medical Association and American College of Physician Executives. As a frontline leader, Dr. Whatley oversaw the care, wellbeing and management of dozens of healthcare workers, and orchestrated the treatment and management of numerous cases of Covid-19 afflicted patients. Dr. Whatley brings her knowledge and experience as a tried & tested leader to the company, to guide a team of innovators to develop technologies that are patient centric.

Exec. Vice-President & COO

Mr. V. B. Carter, BSc., PA-C (Van Carter) is board certified in New York and an alumnus of Long Island University, now Master of Science Physician Associate Program. Van Carter is a prolific inventor & clinician who spearheads the company’s R&D division and IP portfolio. As COO, he meticulously oversees the vision, inspiration, growth, and creativity of Parace Bionics, LLC. With more than 20 years of clinical & hands on engineering experience, the COO guides his team of engineers & Industrial Designers, to develop a vast array of innovative technologies that reaches beyond MedTEc applications. Mr. Carter has received United States patents for technologies in energy recovery for electric vehicles & novel solar cell architecture/technologies. He has pending patents for solar powered sanitation system as well as wind powered mobile generators.

Vice-Pres. & CMO (Asia & Middle East)

Joanne Loo, BSN, RN, (NP candidate) is Chief Marketing Officer for Asia and Middle East region. She is a registered nurse with ten years of experience in medical-surgical, (cardiac) telemetry, women's health oncology, OB/GYN, geriatric care, with hands on application, clinical knowledge and experience with utilizing medical technologies in ambulatory and inpatient setting; held position of Unit-based council chairperson at a Tier 1 hospital. Prior to earning her healthcare degrees, Joanne worked in business management and gained experience managing real estate and retail businesses. Joanne was an invited speaker on the 3rd Nursing World Conference in Rome, Italy 2018, and 4th Nursing World Conference in London, the UK in 2019. She has graced the 'Good Morning America' show on ABC, NBC Megan Kelly show and TODAY show as a fashion and style model. Joanne has traveled extensively throughout Asia, Middle East, Europe & is fluent in Mandarin.

SVP & Chief Compliance Officer

Mr. Fernand A. De Los Reyes, RN, MSc., is SVP & Chief Regulatory Compliance Officer, with an accomplished track record collaborating with USFDA. Mr. De Los Reyes earned a Master of Science in Nursing Degree from the Hunter-Bellevue School of Nursing at the City University of New York (CUNY) with a specialty in Community and Public Health. His Bachelor of Science Degree in Nursing was earned from the Dominican College of Blauvelt, NY. Previously, Mr. De Los Reyes earned a Master of Arts in International Relations from the International University of Japan (IUJ) and a Bachelor of Science in Agricultural Economics (cum laude) from the University of the Philippines at Los Banos. He also attended the University of Tokyo as a graduate research student with a Monbukagakusho scholarship from the Japan Ministry of Education, Culture, Sports, Science and Technology. His work history includes clinical experience in both acute and sub-acute care settings, banking and technology media coverage for a Japanese media firm. Mr. De Los Reyes also teaches nursing courses in New Jersey. Mr. Reyes is fluent in three languages.

SVP, General Counsel & Business Development

Mr. Gilbert Matibag, Esq., SVP., is a former Philippine Assistant Provincial Prosecutor and a former District Public Attorney. He holds a Bachelor of Law degree from San Sebastian College Recoletos & Bachelor of Arts, Major in Philosophy from the Pontifical University of Santo Tomas. Mr. Matibag is the global Director of IP portfolio, Marketing and Licensing.